Danping Guo

710 total citations
19 papers, 584 citations indexed

About

Danping Guo is a scholar working on Molecular Biology, Rheumatology and Physiology. According to data from OpenAlex, Danping Guo has authored 19 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Rheumatology and 6 papers in Physiology. Recurrent topics in Danping Guo's work include Osteoarthritis Treatment and Mechanisms (7 papers), Adenosine and Purinergic Signaling (6 papers) and Receptor Mechanisms and Signaling (6 papers). Danping Guo is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (7 papers), Adenosine and Purinergic Signaling (6 papers) and Receptor Mechanisms and Signaling (6 papers). Danping Guo collaborates with scholars based in United States, Russia and Italy. Danping Guo's co-authors include Lei Ding, Gene A. Homandberg, Kenneth A. Jacobson, T. Kendall Harden, Stefano Moro, José L. Boyer, Emidio Camaioni, James A. Martin, Joseph A. Buckwalter and Joel B. Schachter and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Danping Guo

18 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danping Guo United States 12 306 224 175 111 76 19 584
Isabelle Belloc France 13 330 1.1× 134 0.6× 92 0.5× 35 0.3× 61 0.8× 14 559
David B. Lipshutz United States 7 296 1.0× 11 0.0× 95 0.5× 58 0.5× 38 0.5× 8 542
Ameet A. Chimote United States 15 277 0.9× 81 0.4× 16 0.1× 68 0.6× 12 0.2× 25 519
Zai‐Long Chi China 16 418 1.4× 13 0.1× 31 0.2× 58 0.5× 42 0.6× 37 782
Anita Terse United States 12 265 0.9× 11 0.0× 140 0.8× 81 0.7× 20 0.3× 17 548
Sarah C. Starossom United States 11 274 0.9× 17 0.1× 23 0.1× 60 0.5× 31 0.4× 15 754
Jeffrey L. Edelman United States 15 388 1.3× 16 0.1× 20 0.1× 66 0.6× 35 0.5× 18 1.0k
Qing Ouyang China 17 296 1.0× 42 0.2× 13 0.1× 96 0.9× 43 0.6× 43 649
Ying Yuan China 15 413 1.3× 22 0.1× 41 0.2× 130 1.2× 27 0.4× 35 709

Countries citing papers authored by Danping Guo

Since Specialization
Citations

This map shows the geographic impact of Danping Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danping Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danping Guo more than expected).

Fields of papers citing papers by Danping Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danping Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danping Guo. The network helps show where Danping Guo may publish in the future.

Co-authorship network of co-authors of Danping Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Danping Guo. A scholar is included among the top collaborators of Danping Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danping Guo. Danping Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Johnson, Sarah J., et al.. (2022). Upregulation of PARG in prostate cancer cells suppresses their malignant behavior and downregulates tumor-promoting genes. Biomedicine & Pharmacotherapy. 153. 113504–113504. 3 indexed citations
2.
Guo, Danping, et al.. (2022). Cell-Based Screening for New PARP Inhibitors Utilizing PARG-Mutated Mouse Embryonic Stem Cells. Methods in molecular biology. 2609. 375–385. 1 indexed citations
3.
Johnson, Sarah J., et al.. (2022). PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment. BMC Cancer. 22(1). 557–557. 7 indexed citations
4.
Guo, Danping, et al.. (2021). Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy. Cancers. 13(19). 4973–4973. 12 indexed citations
5.
Lodhi, Niraj, et al.. (2020). Poly(ADP-ribose) polymerase 1 in genome-wide expression control in Drosophila. Scientific Reports. 10(1). 21151–21151. 10 indexed citations
6.
Jiang, Qiaoling, A. Michiel van Rhee, Kenneth A. Jacobson, et al.. (2020). A Mutational Analysis of Residues Essential for Ligand Recognition at the Human P2Y 1 Receptor. UNC Libraries. 1 indexed citations
8.
Ding, Lei, Danping Guo, Gene A. Homandberg, Joseph A. Buckwalter, & James A. Martin. (2014). A single blunt impact on cartilage promotes fibronectin fragmentation and upregulates cartilage degrading stromelysin‐1/matrix metalloproteinase‐3 in a bovine ex vivo model. Journal of Orthopaedic Research®. 32(6). 811–818. 28 indexed citations
9.
Ding, Lei, Emily Heying, Neville Nicholson, et al.. (2010). Mechanical impact induces cartilage degradation via mitogen activated protein kinases. Osteoarthritis and Cartilage. 18(11). 1509–1517. 77 indexed citations
10.
Ding, Lei, Danping Guo, & Gene A. Homandberg. (2009). Fibronectin fragments mediate matrix metalloproteinase upregulation and cartilage damage through proline rich tyrosine kinase 2, c-src, NF-κB and protein kinase Cδ. Osteoarthritis and Cartilage. 17(10). 1385–1392. 39 indexed citations
11.
Guo, Danping, Lei Ding, & Gene A. Homandberg. (2009). Telopeptides of type II collagen upregulate proteinases and damage cartilage but are less effective than highly active fibronectin fragments. Inflammation Research. 58(3). 161–169. 23 indexed citations
12.
Ding, Lei, Danping Guo, & Gene A. Homandberg. (2008). The cartilage chondrolytic mechanism of fibronectin fragments involves MAP kinases: comparison of three fragments and native fibronectin. Osteoarthritis and Cartilage. 16(10). 1253–1262. 49 indexed citations
13.
Ding, Lei & Danping Guo. (2007). Extracellular Matrix Fragments as Regulators of Cartilage Metabolism in Health and Disease. Current Rheumatology Reviews. 3(3). 183–196. 8 indexed citations
14.
Homandberg, Gene A., et al.. (2006). Mixtures of glucosamine and chondroitin sulfate reverse fibronectin fragment mediated damage to cartilage more effectively than either agent alone. Osteoarthritis and Cartilage. 14(8). 793–806. 22 indexed citations
15.
Guo, Danping, Ivar von Kügelgen, Stefano Moro, Yong‐Chul Kim, & Kenneth A. Jacobson. (2002). Evidence for the recognition of non‐nucleotide antagonists within the transmembrane domains of the human P2Y1 receptor. Drug Development Research. 57(4). 173–181. 28 indexed citations
16.
Jacobson, Kenneth A., Carsten Hoffmann, Yong‐Chul Kim, et al.. (1999). Chapter 10 Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis. Progress in brain research. 120. 119–132. 24 indexed citations
17.
Moro, Stefano, Danping Guo, Emidio Camaioni, et al.. (1998). Human P2Y1Receptor:  Molecular Modeling and Site-Directed Mutagenesis as Tools To Identify Agonist and Antagonist Recognition Sites. Journal of Medicinal Chemistry. 41(9). 1456–1466. 126 indexed citations
18.
Jiang, Qiaoling, Danping Guo, A. Michiel van Rhee, et al.. (1997). A Mutational Analysis of Residues Essential for Ligand Recognition at the Human P2Y1 Receptor. Molecular Pharmacology. 52(3). 499–507. 114 indexed citations
19.
Guo, Danping, et al.. (1996). Efficient Insertion of Odd-numbered Transmembrane Segments of the Tetracycline Resistance Protein Requires Even-numbered Segments. Journal of Biological Chemistry. 271(48). 30829–30834. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026